375
Participants
Start Date
December 5, 2024
Primary Completion Date
January 31, 2028
Study Completion Date
July 31, 2028
Tizanidine
Tizanidine 2mg three times a day for 5 weeks after surgery
MI-Opioid Taper
Motivational Interviewing (MI) and guided Opioid Tapering support adapting MI principles for enhancing motivation to change in pain treatment and tailoring key MI tools to postoperative opioid use delivered through weekly phone calls from weeks 2 to 7, and at week 11. The guided opioid tapering protocol will be a 25% total daily opioid dose reduction every 7 days with opioid discontinuation 7 days after reaching 1 opioid pill per day.
Placebo
1 tablet three times a day for 5 weeks after surgery
Enhanced Usual Care
Participants will receive weekly phone calls from weeks 2 to 7, and at week 11. 1 topic per call will be reviewed in this sequence:1) standardized instructions on taking opioid medications after surgery, 2) safe opioid use, 3) avoiding medication errors, 4) local mental health resources and 988 Suicide \& Crisis lifeline, 5) disposal of unused medications, 6) prescription drug abuse, and 7) complementary health approaches for chronic pain. Education materials will be reviewed in a didactic style without a tailored discussion.
RECRUITING
Stanford University Hospital, Stanford
Stanford University
OTHER